Semax

Semax

Semax is a synthetic heptapeptide originally developed as a peptide analog of adrenocorticotropic hormone (ACTH) fragment (4–10), modified to enhance stability while lacking hormonal activity. It has become an important research compound in neuroscience and molecular biology due to its involvement in studies investigating neuropeptide signaling, cellular communication, and central nervous system physiology.

In laboratory and preclinical research, Semax has been investigated for its potential roles in:

• Neurotrophic factor signaling
• Brain-derived neurotrophic factor (BDNF) expression
• Nerve growth factor (NGF) regulation
• Neuronal signaling pathways
• Synaptic plasticity
• Neurotransmitter regulation
• Dopaminergic signaling
• Serotonergic signaling
• Glutamatergic signaling
• Neuronal communication
• Cognitive function research
• Learning and memory pathways
• Cellular stress responses
• Oxidative stress mechanisms
• Neuroinflammatory signaling
• Gene expression regulation
• Mitochondrial function
• Neuroprotective mechanisms
• Central nervous system physiology
• Peptide pharmacology

Semax continues to serve as a valuable research peptide for investigating the molecular mechanisms underlying neuronal signaling, neuroplasticity, and cellular adaptation. Ongoing studies seek to further characterize its pharmacological profile, receptor interactions, and downstream signaling pathways across a variety of experimental models.

Research Use Only (RUO): This product is intended exclusively for laboratory and scientific research. It is not intended for human or veterinary use, diagnosis, treatment, or consumption.